Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 14, 2021
Pace Analytical Life Sciences® announced that it has acquired Velesco Pharmaceutical Services, Inc. Velesco, also a CDMO, specializes in liquid, semi-solid, and oral solid dose product development.
read more
Thursday, October 14, 2021
MilliporeSigma announced the opening of its second Carlsbad, California-based facility, significantly expanding its CDMO footprint. This new $110 million, 140,000-square foot facility will more than double the Life Science business sector's existing ...
read more
Wednesday, October 13, 2021
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global integrated solutions provider, announced it has signed a definitive agreement to acquire Lyophilization Services of New England, Inc. (LSNE), a premier contract ...
read more
Tuesday, October 12, 2021
Humanigen announced it has entered into an arrangement with Clinigen to implement a Managed Access Program for lenzilumab (“LenzMAP™”).
read more
Tuesday, October 12, 2021
The preparation of floors, ceilings, exterior walls, electric service, and plumbing lines is nearly finished at NewAge Industries AdvantaPure’s new Warrington manufacturing facility. With the operational infrastructure approaching completion, ...
read more
Tuesday, October 12, 2021
LSNE Contract Manufacturing, a leading global contract development and manufacturing organization (CDMO), today announces it has doubled its sterile drug product lyophilization capacity at its Madison, Wisconsin parenteral manufacturing facility, ...
read more
IQVIA™, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, announced the opening of a state-of-the-art, 160,000-square-foot lab facility for its Q2 Solutions subsidiary...
read more
Mednet, a healthcare technology company, announced its latest software release featuring expanded trial supply management capabilities. The new Trial Supply Manager, a component of Mednet's Randomization and Trial Supply Management (RTSM) module, ...
read more
AAD, developer of rapid diagnostic and data systems, today announced that it has been awarded a federal contract for the development of an innovative system for the earlier detection of severe infection, including sepsis. The easy-to-use system is ...
read more
HealthVerity announced that it has been awarded a contract with the Centers for Disease Control and Prevention (CDC) to provide a large-scale, fully interoperable, real-world dataset to advance a wide range of COVID-19 research, decision making, and ...
read more
Medidata, a Dassault Systèmes company, today announced that Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, is using Medidata to standardize its clinical trial platform for building out...
read more
Thursday, October 07, 2021
Catalent, a global leader in clinical supply services, today announced the opening of its new clinical supply facility, strategically located in the Shiga prefecture of Japan, in response to increased demand for end-to-end services, including primary...
read more
Thursday, October 07, 2021
BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the full and final transition from Hospira Adelaide ...
read more
Thursday, October 07, 2021
Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in both developed and developing nations, and SiO2 Materials Science, a privately-owned U.S. advanced ...
read more
Thursday, October 07, 2021
Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of RxDataScience, a leading healthcare-focused data analytics, data management and artificial intelligence (AI) company....
read more